Recurrent Soft Tissue Sarcoma Recruiting Phase 2 Trials for Selpercatinib (DB15685)

DBCOND0105100 (Recurrent Soft Tissue Sarcoma)Recruiting2 IdentifierTitlePurposeDrugs
NCT03155620Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)Screening
NCT04320888Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment TrialTreatment